adventitious agent safety
Mitigating the Risks of Contamination in Biopharma
October 18 by Pharma IQ
A crucial consideration in any pharmaceutical manufacturing process, and particularly when work involves biological elements, is how to mitigate the risk of contamination. Experts predict that within...
62.5% of Biologics Professionals Have Strategy in Place to Mitigate Risks of Contamination
September 06 by Pharma IQWithin the next five years, the global biologics market is set to exceed $239 billion (£145 billion) in value, according to recent research by Bharat Book. As innovation brings down production costs a...
Ensuring Adventitious Agent Safety in Biologics
July 26 by Pharma IQBy 2015, the global market for biologics is expected to reach $239 billion (£147 billion), thanks to more comprehensive drugs pipelines, development of biosimilars and innovations to slash production...
Buyer Beware: Are You Reducing the Risk of Adventitious Agents in your Raw Materials?
April 20 by Barbara J. PottsDr. Barbara J. Potts, Senior Consultant, Potts and Nelson Consulting, joins Pharma IQ ahead of the Ensuring Adventitious Agent Safety in Biologics Conference, taking place 17 to 19 October in M...
